Gilead Sciences Short-Term Investments increased by 257.9% to $68.00M in Q4 2025 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows a downward trend with a -45.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.
Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...
Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.
short_term_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.38B | $1.18B | $1.03B | $924.00M | $961.00M | $973.00M | $936.00M | $963.00M | $1.16B | $1.18B | $0.00 | $0.00 | $0.00 | $0.00 | $69.00M | $19.00M | $68.00M |
| QoQ Change | — | -15.7% | -14.1% | -12.9% | -10.2% | +4.0% | +1.2% | -3.8% | +2.9% | +20.4% | +1.7% | -100.0% | — | — | — | — | -72.5% | +257.9% |
| YoY Change | — | — | — | — | -43.4% | -30.2% | -17.7% | -9.0% | +4.2% | +20.6% | +21.2% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.